Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Pivotal Inflammatory Players Revealed in Diabetic Kidney Disease

April 11, 2016 8:29 am | by undefined | News | Comments

Diabetic kidney disease is the leading cause of end-stage kidney disease. Read more...


The Surge in Diabetes Worldwide

April 11, 2016 8:23 am | by Stephanie Guzowski, Editor | News | Comments

The number of adults with diabetes worldwide has quadrupled since 1980, with a majority of the disease burden in low and middle income countries: Chart depiction.


Tailoring a Suit for Tumor-Penetrating Cancer Meds

April 11, 2016 8:22 am | by Drexel University | News | Comments

Targeted cancer therapy is most effective when the medication is released as close as possible to the interior of a tumor. Read more...


Is a Popular Painkiller Hampering Our Ability to Notice Errors?

April 10, 2016 10:30 am | by University of Toronto | News | Comments

Acetaminophen is an effective pain-killer, but could also impede error-detection. Read more...


WHO: Diabetes Rises Fourfold Over Last-Quarter Century

April 9, 2016 11:30 am | by Jamey Keaten, Associated Press | News | Comments

The increase has coincided with growing rates of obesity. Read more...


Common Prostate Cancer Treatments Suppress Immune Response

April 9, 2016 10:30 am | by UT Southwestern Medical Center | News | Comments

ADTs are anti-hormone therapies that decrease the body’s levels of androgens. Read more...


Puerto Rico Sees 436 Zika Cases; 60 Pregnant Women Infected

April 8, 2016 3:25 pm | News | Comments

​Zika cases in the U.S. territory of Puerto Rico have jumped to 436 so far this year.

FDA Recommends Approval of Intercept's Liver Disease Drug

April 8, 2016 2:11 pm | News | Comments

PBC is a rare chronic liver disease.


High Vitamin D Levels Correspond to Lower Cancer Risk

April 8, 2016 2:06 pm | by University of California, San Diego | News | Comments

The only accurate measure of vitamin D levels in a person is a blood test. Read more...


Drug Discovery Spotlight: Next Steps for Pfizer, Allergan; Drug Discovery in the Greenhouse

April 8, 2016 11:24 am | by Stephanie Guzowski, Editor | News | Comments

Welcome to Drug Discovery Spotlight — we’ve rounded up this week’s top news, trending headlines, and all-around interesting reads. Read more..


After Allergan Merger Halt, Vaccines a Focus for Pfizer: Kalorama

April 8, 2016 10:00 am | News | Comments

Pfizer will now consider business divestitures in order to boost its profits. Read more...


Eli Lilly, AstraZeneca: Clinical Trial Continued for Early Alzheimer's Disease

April 8, 2016 9:57 am | News | Comments

Phase 2/3 trial of AZD3293, an oral potent small molecule BACE inhibitor, will continue to Phase 3 after positive interim safety data. Read more...


Pfizer, IBM to Collaborate on Parkinson's Research

April 8, 2016 9:48 am | News | Comments

The ultimate goal is to obtain a better understanding of a patient’s disease progression and medication response. Read more...


NIH Launches Large Clinical Trials of Antibody-based HIV Prevention

April 8, 2016 9:47 am | by NIH/NIAID | News | Comments

The volunteers in both studies will be adults at high risk for HIV infection, but HIV-negative when they enter the study.  Read more...


HIV Can Develop Resistance to CRISPR/Cas9

April 8, 2016 9:45 am | by Cell Press | News | Comments

The CRISPR/Cas9 gene-editing platform may need a little bit more tweaking before it can be used as an effective antiviral, reports a study published April 7 in Cell Reports.  Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.